Company Profile

Company Description

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with disorders related to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. Their pipeline includes novel therapies targeting hematologic, pulmonary, and cardiovascular diseases. By leveraging deep scientific expertise, the company aims to address unmet medical needs through precision medicine approaches, with a strong emphasis on improving patient outcomes in serious and rare conditions. Their research is centered on modulating key biological pathways to restore proper cellular function and promote tissue repair.